Series B startup

Who invested in Rebound Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$17Mraised across 1 round since 2017, from 1 source

Latest round
Series B, $17MJul 2017
Investors
1
See who backed them

The rounds

  1. Jul 2017
    Series B$17M

    Source recordedSEC filing: $16M sold, first sale Jul 2017

Everyone who backed them

InvusPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Rebound Therapeutics

Who invested in Rebound Therapeutics?

Rebound Therapeutics's investors include Invus.

How much has Rebound Therapeutics raised?

Rebound Therapeutics has raised $17M across 1 round since 2017.

When did Rebound Therapeutics last raise?

Rebound Therapeutics's most recent round was a Series B of $17M in Jul 2017.

What was Rebound Therapeutics's biggest round?

Its most recent round, $17M in Jul 2017, is also its largest on record.

Who backed Rebound Therapeutics first?

Rebound Therapeutics's first round on record, in Jul 2017, was backed by Invus.

What stage is Rebound Therapeutics at?

Rebound Therapeutics's latest named round is a Series B, in Jul 2017.

Companies like Rebound Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.